Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 12 April 2011
Vol. 4, Issue 168, p. ra23
[DOI: 10.1126/scisignal.2001617]
RESEARCH ARTICLES
PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes
Suhasini Kulkarni1,
Cassian Sitaru2,3,
Zoltan Jakus4,
Karen E. Anderson1,
George Damoulakis1,
Keith Davidson1,
Misa Hirose2,
Jatinder Juss1,
David Oxley1,
Tamara A. M. Chessa1,
Faruk Ramadani5,
Herve Guillou1,
Anne Segonds-Pichon1,
Anja Fritsch6,
Gavin E. Jarvis7,
Klaus Okkenhaug5,
Ralf Ludwig2,
Detlef Zillikens2,
Attila Mocsai4,
Bart Vanhaesebroeck8,
Len R. Stephens1*, and
Phillip T. Hawkins1*
1 Inositide Laboratory, The Babraham Institute, Cambridge CB22 3AT, UK. 2 Department of Dermatology, University of Lübeck, 23538 Lübeck, Germany. 3 Department of Dermatology and Centre for Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany. 4 Department of Physiology, Semmelweis University School of Medicine, P.O. Box 259, 1444 Budapest, Hungary. 5 Laboratory of Lymphocyte Signaling and Development, The Babraham Institute, Cambridge CB22 3AT, UK. 6 Department of Dermatology, University Medical Centre, 79104 Freiburg, Germany. 7 Department of Biochemistry, University of Cambridge, Cambridge CB2 1QW, UK. 8 Centre for Cell Signaling, Institute of Cancer, Queen Mary University of London, London EC1M 6BQ, UK.
* These authors contributed equally to this work.
Abstract:
Neutrophils are activated by immunoglobulin G (IgG)–containing immune complexes through receptors that recognize the Fc portion of IgG (FcRs). Here, we used genetic and pharmacological approaches to define a selective role for the β isoform of phosphoinositide 3-kinase (PI3Kβ) in FcR-dependent activation of mouse neutrophils by immune complexes of IgG and antigen immobilized on a plate surface. At low concentrations of immune complexes, loss of PI3Kβ alone substantially inhibited the production of reactive oxygen species (ROS) by neutrophils, whereas at higher doses, similar suppression of ROS production was achieved only by targeting both PI3Kβ and PI3K, suggesting that this pathway displays stimulus strength–dependent redundancy. Activation of PI3Kβ by immune complexes involved cooperation between FcRs and BLT1, the receptor for the endogenous proinflammatory lipid leukotriene B4. Coincident activation by a tyrosine kinase–coupled receptor (FcR) and a heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptor (BLT1) may provide a rationale for the preferential activation of the β isoform of PI3K. PI3Kβ-deficient mice were highly protected in an FcR-dependent model of autoantibody-induced skin blistering and were partially protected in an FcR-dependent model of inflammatory arthritis, whereas combined deficiency of PI3Kβ and PI3K resulted in near-complete protection in the latter case. These results define PI3Kβ as a potential therapeutic target in inflammatory disease.
To whom correspondence should be addressed. E-mail: phillip.hawkins{at}bbsrc.ac.uk (P.T.H.); len.stephens{at}bbsrc.ac.uk (L.R.S.)
Citation: S. Kulkarni, C. Sitaru, Z. Jakus, K. E. Anderson, G. Damoulakis, K. Davidson, M. Hirose, J. Juss, D. Oxley, T. A. M. Chessa, F. Ramadani, H. Guillou, A. Segonds-Pichon, A. Fritsch, G. E. Jarvis, K. Okkenhaug, R. Ludwig, D. Zillikens, A. Mocsai, B. Vanhaesebroeck, L. R. Stephens, P. T. Hawkins, PI3Kβ Plays a Critical Role in Neutrophil Activation by Immune Complexes. Sci. Signal.4, ra23 (2011).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
RESEARCH ARTICLES
Hashem A. Dbouk, Oscar Vadas, Aliaksei Shymanets, John E. Burke, Rachel S. Salamon, Bassem D. Khalil, Mathew O. Barrett, Gary L. Waldo, Chinmay Surve, Christine Hsueh, Olga Perisic, Christian Harteneck, Peter R. Shepherd, T. Kendall Harden, Alan V. Smrcka, Ronald Taussig, Anne R. Bresnick, Bernd Nürnberg, Roger L. Williams, and Jonathan M. Backer (4 December 2012) Sci. Signal.5 (253), ra89.
[DOI: 10.1126/scisignal.2003264] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
EDITORS' CHOICE
John F. Foley (10 May 2011) Sci. Signal.4 (172), ec133.
[DOI: 10.1126/scisignal.4172ec133] |Abstract »
RESEARCH ARTICLES
Faruk Ramadani, Daniel J. Bolland, Fabien Garcon, Juliet L. Emery, Bart Vanhaesebroeck, Anne E. Corcoran, and Klaus Okkenhaug (10 August 2010) Sci. Signal.3 (134), ra60.
[DOI: 10.1126/scisignal.2001104] |Editor's Summary »|Abstract »|Full Text »|PDF »|Supplementary Materials »
Class I Phosphoinositide-3-Kinases and Src Kinases Play a Nonredundant Role in Regulation of Adhesion-Independent and -Dependent Neutrophil Reactive Oxygen Species Generation.
L. Fumagalli, C. C. Campa, G. Germena, C. A. Lowell, E. Hirsch, and G. Berton (2013)
J. Immunol.
190, 3648-3660
|Abstract »|Full Text »|PDF »
Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b {beta}2-integrin-dependent signaling.
S. J. McMillan, R. S. Sharma, E. J. McKenzie, H. E. Richards, J. Zhang, A. Prescott, and P. R. Crocker (2013)
Blood
121, 2084-2094
|Abstract »|Full Text »|PDF »
G Protein-Coupled Receptor-Mediated Activation of p110{beta} by G{beta}{gamma} Is Required for Cellular Transformation and Invasiveness.
H. A. Dbouk, O. Vadas, A. Shymanets, J. E. Burke, R. S. Salamon, B. D. Khalil, M. O. Barrett, G. L. Waldo, C. Surve, C. Hsueh, et al. (2012)
Science Signaling
5, ra89
|Abstract »|Full Text »|PDF »
Insulin Modulates the Inflammatory Granulocyte Response to Streptococci via Phosphatidylinositol 3-Kinase.
S. Kenzel, M. Mergen, J. von Susskind-Schwendi, J. Wennekamp, S. D. Deshmukh, M. Haeffner, A. Triantafyllopoulou, S. Fuchs, S. Farmand, S. Santos-Sierra, et al. (2012)
J. Immunol.
189, 4582-4591
|Abstract »|Full Text »|PDF »
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies.
J. G. Foster, M. D. Blunt, E. Carter, and S. G. Ward (2012)
Pharmacol. Rev.
64, 1027-1054
|Abstract »|Full Text »|PDF »
Emerging anti-inflammatory strategies for COPD.
M. Cazzola, C. P. Page, L. Calzetta, and M. G. Matera (2012)
Eur. Respir. J.
40, 724-741
|Abstract »|Full Text »|PDF »
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases.
O. Vadas, J. E. Burke, X. Zhang, A. Berndt, and R. L. Williams (2011)
Science Signaling
4, re2
|Abstract »|Full Text »|PDF »